GH Stock Summary and Trading Ideas (Guardant Health | NASDAQ:GH)

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

What symbol and exchange does Guardant Health shares trade?

Guardant Health trades on the NASDAQ stock market under the symbol GH.

What is Guardant Health stock price doing today?

As of December 17, 2025, GH stock price declined to $97.47 with 1,704,568 million shares trading.

What is Guardant Health's Beta?

GH has a beta of 1.11, meaning it tends to be more sensitive to market movements. GH has a correlation of 0.09 to the broad based SPY ETF.

How much is Guardant Health worth?

GH has a market cap of $12.66 billion. This is considered a Large Cap stock.

How much money does Guardant Health make?

Last quarter Guardant Health reported $265 million in Revenue and -$.39 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.22.

What is the highest and lowest price Guardant Health traded in the last 3 year period?

In the last 3 years, GH traded as high as $112.43 and as low as $15.81.

What are the top ETFs holding Guardant Health?

The top ETF exchange traded funds that GH belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.

Is Guardant Health (GH) a good investment?

GH has outperformed the market in the last year with a return of +173.6%, while the SPY ETF gained +11.8%. In the last 3 month period, GH beat the market returning +75.9%, while SPY returned +2.0%. However, in the most recent 2 weeks GH has underperformed the stock market by returning -6.2%, while SPY returned -1.5%.

What are the support and resistance levels for Guardant Health (GH)?

GH support price is $96.43 and resistance is $103.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GH shares will trade within this expected range on the day.